ABCB1 and ABCG2 restricts the efficacy of gedatolisib (PF-05212384), a PI3K inhibitor in colorectal cancer cells

Changfu Liu(Tianjin Medical University Cancer Institute and Hospital), Tongguo Si(Tianjin Medical University Cancer Institute and Hospital)
Cancer Cell International
February 16, 2021
Cited by 34


Related Papers